Survival of pleural malignant mesothelioma in Italy: A population-based study

International Journal of Cancer

Volumn 124, Issue 1, 2009, Pages 201-207

  Montanaro, Fabio ^a   Rosato, Rosalba ^b   Gangemi, Manuela ^b   Roberti, Sara ^c   Ricceri, Fulvio ^d   Merler, Enzo ^c   Gennaro, Valerio ^a   Romanelli, Antonio ^e   Chellini, Elisabetta ^f   Pascucci, Cristiana ^g   Musti, Marina ^h   Nicita, Carmela ⁱ   Barbieri, Pietro Gino ^j   Marinaccio, Alessandro ^k   Magnani, Corrado ^l   Mirabelli, Dario ^b,m  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Padua Local Health Authority   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e Department of Public Health   (Italy)

^f CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^g UNIVERSITY OF CAMERINO   (Italy)

^h UNIVERSITY OF BARI   (Italy)

ⁱ CIVILE M P AREZZO HOSPITAL   (Italy)

^j Brescia Local Health Authority   (Italy)

^k ISPESL   (Italy)

^l UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^m Unit of Cancer Epidemiology   (Italy)

more..

Author keywords

Malignant mesothelioma; Pleura; Survival

Indexed keywords

ASBESTOS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HISTOPATHOLOGY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; PLEURAL MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SURVIVAL TIME; MESOTHELIOMA; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PLEURA TUMOR; PROPORTIONAL HAZARDS MODEL; REGISTER; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; ITALY; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLEURAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TREATMENT OUTCOME;

EID: 58149376997     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23874     Document Type: Article

References (28)

1. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br. J Cancer 1999;79:666-72.
2. Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E. The Mesothelioma epidemic in Western Europe: an update. Br. J Cancer 2004;90:1022-4.
3. Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, Strnad M, Jechov'a M, Storm HH, Aareleid T, Hakulinen T, Velten M et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 2003;14:791-803.
4. Marinaccio A, Montanaro F, Mastrantonio M, Uccelli R, Altavista P, Nesti M, Costantini AS, Gorini G. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer 2005;115:142-7.
5. Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005;366:397-408.
6. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Phase III Study of Pemetrexed in combination with Cisplatin versus Cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44.
7. Weder W, Stahel R, Bernhard J, Bodis S, Vogt P, Ballabeni P, Lardinois D, Betticher D, Schmid R, Stupp R, Ris H, Jermann M, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-202.
8. Rea F, Marulli G, Bortolotti L, Breda C, Favaretto AG, Loreggian L, Sartori F. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 2007;57:89-95.
9. Janssen-Heijnen ML, Damhuis RA, Klinkhamer PJ, Schipper RM, Coebergh JW. Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population-based study. Eur J Cancer Prev 1999;8:311-4.
10. Neumann V, Günthe S, Mülle KM, Fischer M. Malignant mesothelioma-German mesothelioma register 1987-1999. Int Arch Occup Environ Health 2001;74:383-95.
11. Desoubeaux N, Bouvier V, Gervais R, Galateau-Salle F, Thibon P, Leplumey T, Herbert C, Lecherbonnier Y, Daviet JP, Letourneux M. Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival. [in. French]. Rev Epidemiol Samé Publique 2001;49:523-9.
12. Magnani C, Viscomi S, Dalmasso P, Ivaldi C, Mirabelli D, Terracini B. Survival after pleural malignant mesothelioma: a population-based study in Italy. Tumori 2002;88:266-9.
13. Marinaccio A, Nesti M; Regional Operational Centers. Analysis of survival of mesothelioma cases in the Italian register (ReNaM). Eur J Cancer 2003;39:1290-5.
14. Barbieri PG, Marinaccio A, Festa R, Nesti M, Marchetti G, Trigiani M, Tassi G. Survival analysis of malignant mesothelioma treated in Brescia, northern Italy, 1982-2000. [in Italian] Epidemiol Prev 2004;28:107-13.
15. Gorini G, De Gregorio G, Silvestri S, Chellini E, Cupelli V, Seniori Costantini A. Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study. Eur J Cancer Prev 2005;14:195-9.
16. Kanazawa N, Ioka A, Tsukuma H, Ajiki W, Oshima A. Incidence and survival of mesothelioma in Osaka, Japan. Jpn J Clin Oncol 2006;36:254-7.
17. Decreto Legislativo 15 agosto 1991, numero 277 [in Italian]. Gazzetta Ufficiale della Repubblica Italiana numero 200 (supplemento ordinario), 27 agosto 1991.
18. Moccaldi A, Palmi S, Nesti M. Linee guida per la rilevazione e la definizione dei casi di mesotelioma maligno e la trasmissione delle informazioni all'ISPESL da parte dei centri operativi regionali. Seconda edizione. Rome (Italy): Istituto Superiore per la Prevenzione e la Sicurezza sul Lavoro; 2003 [in Italian].
19. Nesti M, Marinaccio A, Gennaro V, Gorini G, Mirabelli D, Mensi C, Merler E, Montanaro F, Musti M, Pannelli F, Romanelli A, Tumino R, et al. Epidemiologic surveillance for primary prevention of malignant mesothelioma: the Italian experience. [in Italian] Med Lav 2005;96:338-46.
20. Nesti M, Marinaccio A, Chellini E; Regional Operational Centers. Malignant mesothelioma in Italy, 1997. Am J Ind Med 2004;45:55-62.
21. Marinaccio A, Binazzi A, Cauzillo G, Cavone D, De Zotti R, Ferrante P, Gennaro V, Gorini G, Menegozzo M, Mensi C, Merler E, Mirabelli D, et al. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer 2007;43:2722-8.
22. Pheby D, Sauvage M, Martinez Garcia C, Schouten L. Incidence date. In: Tyczynsky JE, Demaret E, Parkin DM, eds. Standards and Guidelines for Cancer Registration in Europe. The ENCR Recommendationts. IARC Technical Publication 40; vol.1. Lyon (France): IARC, 2003.
23. Stata 9.2 Statacorp Lakeway Drive, College Station, Texas 2007.
24. Rosso S, Casella C, Crocetti E, Ferretti S, Guzzinati S, eds. Survival of cancer patients in Italy in the nineties: figures from the cancer registries. Epidemiol Prev 2001;25 (Suppl 1):161-3 [in Italian].
25. Merler E, Roberti S. Il ruolo dell'esposizione lavorativa ed ambientale ad amianto nella genesi dei casi di mesotelioma insorti in residenti del Veneto. Mestre (Italy): Regione del Veneto; 2006.36-40 [in Italian].
26. Chapman A, Mulrennan S, Ladd B, Muers MF. Population-based epidemiology and prognosis of mesothelioma in Leeds, United Kingdom. Thorax 2008;63:435-9.
27. Mirabelli D, Roberti S, Gangemi M, Rosato R, Ricceri F, Merler E, Gennaro V, Romanelli A, Gorini G, Pascucci C, Cavone D, Nicita C et al. Survival of peritoneal malignant mesothelioma in Italy: a population-based study. Int J Cancer, 2008; DOI 10.1002/ijc23866.
28. http://seer.cancer.gov/resources/ (Accessed on June 2, 2008).